Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2000 1
2002 4
2003 6
2004 4
2005 16
2006 26
2007 13
2008 15
2009 13
2010 17
2011 4
2012 15
2013 18
2014 17
2015 28
2016 41
2017 42
2018 68
2019 52
2020 77
2021 69
2022 84
2023 101
2024 100
2025 149
2026 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

913 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jun he (2,985 results)?
Phaeohyphomycosis in China.
He Y, Zheng HL, Mei H, Lv GX, Liu WD, Li XF. He Y, et al. Front Cell Infect Microbiol. 2022 Jun 13;12:895329. doi: 10.3389/fcimb.2022.895329. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35770068 Free PMC article. Review.
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release.
Gaspar M, Natoli M, Castan L, Rahmy S, Korade M 3rd, Kelton C, Mulgrew K, Huhn O, Rees DG, Sigurdardottir A, Lloyd C, Taylor JJ, Brailey PM, Dallaway L, Toloczko A, Giraldo N, Broggi MAS, Kunihiro A, Abhishek S, He Y, Rong Y, Eyles J, Ball K, Fitzgerald J, Hammond SA, Cemerski S, Dovedi SJ, Cobbold M. Gaspar M, et al. Among authors: he y. J Immunother Cancer. 2025 Aug 4;13(8):e011857. doi: 10.1136/jitc-2025-011857. J Immunother Cancer. 2025. PMID: 40759445 Free PMC article.
Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging.
Zhang Y, Deng Y, Zou Q, Jing B, Cai P, Tian X, Yang Y, Li B, Liu F, Li Z, Liu Z, Feng S, Peng T, Dong Y, Wang X, Ruan G, He Y, Cui C, Li J, Luo X, Huang H, Chen H, Li S, Sun Y, Xie C, Wang L, Li C, Cai Q. Zhang Y, et al. Among authors: he y. Cell Rep Med. 2024 May 21;5(5):101551. doi: 10.1016/j.xcrm.2024.101551. Epub 2024 May 1. Cell Rep Med. 2024. PMID: 38697104 Free PMC article.
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial.
Cascone T, Bonanno L, Guisier F, Insa A, Liberman M, Bylicki O, Livi L, Egenod T, Corre R, Kim DW, Garcia Campelo MR, Provencio Pulla M, Shim BY, Metro G, Bennouna J, Bielska AA, Yohannes AR, He Y, Dowson A, Kar G, McGrath L, Kumar R, Grenga I, Spicer J, Forde PM. Cascone T, et al. Among authors: he y. Nat Med. 2025 Aug;31(8):2788-2796. doi: 10.1038/s41591-025-03746-z. Epub 2025 May 31. Nat Med. 2025. PMID: 40450142 Free PMC article. Clinical Trial.
Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants.
Liang C, Li R, Pu Z, Chen R, Li Y, Chen S, Feng J, Liu J, Bai Y, Qin X, Xie C, Zhang Y, Peng Y, Tang H, Zhang M, Zhang Q, Wang T, Li B, Zhang H, Zhang X, He Y, He X, Pan T, Zhang H, Zhang Y. Liang C, et al. Among authors: he y. J Nanobiotechnology. 2025 Jul 3;23(1):483. doi: 10.1186/s12951-025-03582-w. J Nanobiotechnology. 2025. PMID: 40611257 Free PMC article.
Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: An open-label pilot study.
Zhao P, An ZY, Fu HX, Liu HX, Feng CJ, Huang QS, Wu J, Wu YJ, Yang LP, Qu QY, Chen YX, Li ML, Wang CC, Chen Q, Zhu XL, He Y, Zhang YY, Jiang Q, Jiang H, Lu J, Chang YJ, Zhao XS, Zhao XY, Huang XJ, Zhang XH. Zhao P, et al. Among authors: he y. Am J Hematol. 2024 Oct;99(10):1951-1958. doi: 10.1002/ajh.27433. Epub 2024 Jul 9. Am J Hematol. 2024. PMID: 38980207 Free article. Clinical Trial.
913 results